RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-024-51828-2
Download full text from publisher
References listed on IDEAS
- Jonathan M. Ostrem & Ulf Peters & Martin L. Sos & James A. Wells & Kevan M. Shokat, 2013. "K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions," Nature, Nature, vol. 503(7477), pages 548-551, November.
- Philip East & Gavin P. Kelly & Dhruva Biswas & Michela Marani & David C. Hancock & Todd Creasy & Kris Sachsenmeier & Charles Swanton & Julian Downward & Sophie de Carné Trécesson, 2022. "RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
- Matteo Cereda & Gennaro Gambardella & Lorena Benedetti & Fabio Iannelli & Dominic Patel & Gianluca Basso & Rosalinda F. Guerra & Thanos P. Mourikis & Ignazio Puccio & Shruti Sinha & Luigi Laghi & Jo S, 2016. "Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes," Nature Communications, Nature, vol. 7(1), pages 1-12, November.
- Matthew Holderfield & Bianca J. Lee & Jingjing Jiang & Aidan Tomlinson & Kyle J. Seamon & Alessia Mira & Enrico Patrucco & Grace Goodhart & Julien Dilly & Yevgeniy Gindin & Nuntana Dinglasan & Yingyun, 2024. "Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy," Nature, Nature, vol. 629(8013), pages 919-926, May.
- Jude Canon & Karen Rex & Anne Y. Saiki & Christopher Mohr & Keegan Cooke & Dhanashri Bagal & Kevin Gaida & Tyler Holt & Charles G. Knutson & Neelima Koppada & Brian A. Lanman & Jonathan Werner & Aaron, 2019. "The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity," Nature, Nature, vol. 575(7781), pages 217-223, November.
- Dongsung Kim & Lorenz Herdeis & Dorothea Rudolph & Yulei Zhao & Jark Böttcher & Alberto Vides & Carlos I. Ayala-Santos & Yasin Pourfarjam & Antonio Cuevas-Navarro & Jenny Y. Xue & Andreas Mantoulidis , 2023. "Pan-KRAS inhibitor disables oncogenic signalling and tumour growth," Nature, Nature, vol. 619(7968), pages 160-166, July.
- Edoardo Morandi & Matteo Cereda & Danny Incarnato & Caterina Parlato & Giulia Basile & Francesca Anselmi & Andrea Lauria & Lisa Marie Simon & Isabelle Laurence Polignano & Francesca Arruga & Silvia De, 2019. "HaTSPiL: A modular pipeline for high-throughput sequencing data analysis," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-9, October.
- Yulei Zhao & Yonina R. Murciano-Goroff & Jenny Y. Xue & Agnes Ang & Jessica Lucas & Trang T. Mai & Arnaud F. Cruz Paula & Anne Y. Saiki & Deanna Mohn & Pragathi Achanta & Ann E. Sisk & Kanika S. Arora, 2021. "Diverse alterations associated with resistance to KRAS(G12C) inhibition," Nature, Nature, vol. 599(7886), pages 679-683, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Johanna Lilja & Jasmin Kaivola & James R. W. Conway & Joni Vuorio & Hanna Parkkola & Pekka Roivas & Michal Dibus & Megan R. Chastney & Taru Varila & Guillaume Jacquemet & Emilia Peuhu & Emily Wang & U, 2024. "SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
- Chi Zhou & Wenxin Li & Zhenxing Liang & Xianrui Wu & Sijing Cheng & Jianhong Peng & Kaixuan Zeng & Weihao Li & Ping Lan & Xin Yang & Li Xiong & Ziwei Zeng & Xiaobin Zheng & Liang Huang & Wenhua Fan & , 2024. "Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Hidenori Kitai & Philip H. Choi & Yu C. Yang & Jacob A. Boyer & Adele Whaley & Priya Pancholi & Claire Thant & Jason Reiter & Kevin Chen & Vladimir Markov & Hirokazu Taniguchi & Rui Yamaguchi & Hiromi, 2024. "Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Kai-Bo Wang & Yushuang Liu & Jinzhu Li & Chengmei Xiao & Yingying Wang & Wei Gu & Yipu Li & Yuan-Zheng Xia & Tingdong Yan & Ming-Hua Yang & Ling-Yi Kong, 2022. "Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Panayiotis Anastasiou & Christopher Moore & Sareena Rana & Mona Tomaschko & Claire E. Pillsbury & Andrea Castro & Jesse Boumelha & Edurne Mugarza & Sophie Carné Trécesson & Ania Mikolajczak & Cristina, 2024. "Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Katharine M. Wright & Sarah R. DiNapoli & Michelle S. Miller & P. Aitana Azurmendi & Xiaowei Zhao & Zhiheng Yu & Mayukh Chakrabarti & WuXian Shi & Jacqueline Douglass & Michael S. Hwang & Emily Han-Ch, 2023. "Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
- Irati Macaya & Marta Roman & Connor Welch & Rodrigo Entrialgo-Cadierno & Marina Salmon & Alba Santos & Iker Feliu & Joanna Kovalski & Ines Lopez & Maria Rodriguez-Remirez & Sara Palomino-Echeverria & , 2023. "Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
- Dan Lu & Yuan Chen & Min Jiang & Jie Wang & Yiting Li & Keke Ma & Wenqiao Sun & Xing Zheng & Jianxun Qi & Wenjing Jin & Yu Chen & Yan Chai & Catherine W. H. Zhang & Hao Liang & Shuguang Tan & George F, 2023. "KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- James Schiemer & Andrew Maxwell & Reto Horst & Shenping Liu & Daniel P. Uccello & Kris Borzilleri & Nisha Rajamohan & Matthew F. Brown & Matthew F. Calabrese, 2023. "A covalent BTK ternary complex compatible with targeted protein degradation," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
- Arafath K. Najumudeen & Sigrid K. Fey & Laura M. Millett & Catriona A. Ford & Kathryn Gilroy & Nuray Gunduz & Rachel A. Ridgway & Eve Anderson & Douglas Strathdee & William Clark & Colin Nixon & Jenni, 2024. "KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Shizhong Ke & Fabin Dang & Lin Wang & Jia-Yun Chen & Mandar T. Naik & Wenxue Li & Abhishek Thavamani & Nami Kim & Nandita M. Naik & Huaxiu Sui & Wei Tang & Chenxi Qiu & Kazuhiro Koikawa & Felipe Batal, 2024. "Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Caterina Bartolacci & Cristina Andreani & Gonçalo Vale & Stefano Berto & Margherita Melegari & Anna Colleen Crouch & Dodge L. Baluya & George Kemble & Kurt Hodges & Jacqueline Starrett & Katerina Poli, 2022. "Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Christel F. A. Ramirez & Daniel Taranto & Masami Ando-Kuri & Marnix H. P. Groot & Efi Tsouri & Zhijie Huang & Daniel Groot & Roelof J. C. Kluin & Daan J. Kloosterman & Joanne Verheij & Jing Xu & Seren, 2024. "Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
- Md Amin Hossain & Rutali R. Brahme & Brandon C. Miller & Jakal Amin & Marcela Barros & Jaime L. Schneider & Jared R. Auclair & Carla Mattos & Qingping Wang & Nathalie Y. R. Agar & David J. Greenblatt , 2025. "Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug development," Nature Communications, Nature, vol. 16(1), pages 1-14, December.
- Swee Y. Sharp & Marianna Martella & Sabrina D’Agostino & Christopher I. Milton & George Ward & Andrew J. Woodhead & Caroline J. Richardson & Maria G. Carr & Elisabetta Chiarparin & Benjamin D. Cons & , 2024. "Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Haochen Zhang & Elias-Ramzey Karnoub & Shigeaki Umeda & Ronan Chaligné & Ignas Masilionis & Caitlin A. McIntyre & Palash Sashittal & Akimasa Hayashi & Amanda Zucker & Katelyn Mullen & Jungeui Hong & A, 2023. "Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
- Alexander Chan & Rebecca M. Haley & Mohd Altaf Najar & David Gonzalez-Martinez & Lukasz J. Bugaj & George M. Burslem & Michael J. Mitchell & Andrew Tsourkas, 2024. "Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Han Koo & Kyung Chan Park & Hyun Ahm Sohn & Minho Kang & Dong Joon Kim & Zee-Yong Park & Sehoon Park & Sang Hyun Min & Seong-Hwan Park & Yeon-Mi You & Yohan Han & Bo-Kyung Kim & Chul-Ho Lee & Yeon-Soo, 2025. "Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
- Kaja Kostyrko & Marta Román & Alex G. Lee & David R. Simpson & Phuong T. Dinh & Stanley G. Leung & Kieren D. Marini & Marcus R. Kelly & Joshua Broyde & Andrea Califano & Peter K. Jackson & E. Alejandr, 2023. "UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Yong Yi & Guoqiang Wang & Wenhua Zhang & Shuhan Yu & Junjie Fei & Tingting An & Jianqiao Yi & Fengtian Li & Ting Huang & Jian Yang & Mengmeng Niu & Yang Wang & Chuan Xu & Zhi-Xiong Jim Xiao, 2025. "Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51828-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.